Scarica l'app Stockscreener
19.52
2.11%
-0.42
Dopo l'orario di chiusura:
19.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$19.94
Aprire:
$19.85
Volume 24 ore:
3.26M
Relative Volume:
0.89
Capitalizzazione di mercato:
$3.57B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
16.39
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
+1.35%
1M Prestazione:
-18.70%
6M Prestazione:
-61.70%
1 anno Prestazione:
-61.74%
Intervallo 1D:
$19.40
$20.00
Intervallo di 1 settimana:
$18.36
$20.00
Portata 52W:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
19.52 | 3.65B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
158.54 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.66 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.25 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Downgrade | Truist | Buy → Hold |
| 2026-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Doximity's (NYSE:DOCS) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Investors to Reach Out - ACCESS Newswire
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Doximity AI Push Reshapes Healthcare Tech On Russell 1000 - Kalkine Media
Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point To A Promising 26% Upside - DirectorsTalk Interviews
Can Russell 1000 Pressure Weigh on Doximity Shares? - Kalkine Media
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - Yahoo Finance
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - The Motley Fool
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
Doximity’s SWOT analysis: stock faces pressure from AI spending, slowing growth - Investing.com
Doximity shares hit record low as soft guidance and AI margin pressures spark 25% plunge - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility - MSN
Handelsbanken Fonder AB Sells 315,900 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat
Doximity to Present at the William Blair 46th Annual Growth Stock Conference - 01net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call - Yahoo Finance
AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity - TipRanks
Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook - Yahoo Finance
Stock market today: S&P 500, Dow, Nasdaq futures gain as Trump clears NVDA's H200 sales to China—Cisco Systems, Doximity in focus (updated) - MSN
DOCS Stock Price, Quote & Chart | DOXIMITY INC-CLASS A (NYSE:DOCS) - ChartMill
Is It Time To Reassess Doximity (DOCS) After Its Sharp Share Price Slide? - simplywall.st
1,246 Doximity (DOCS) shares withheld to cover RSU taxes for interim PFO - Stock Titan
Doximity (NYSE: DOCS) CEO granted PSUs while shares withheld for tax - Stock Titan
Doximity (DOCS) outlines physician network, Clinical AI Suite and main business risks - Stock Titan
Why Are Doximity (DOCS) Shares Soaring Today - Yahoo Finance
J.P. Morgan Upgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $28 - Moomoo
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds - Yahoo Finance
Why Doximity (DOCS) Shares Are Sliding Today - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 1,298,492 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI SpendWhat's Changed - Sahm
Doximity Stock Hits Day Low of $17.16 Amid Price Pressure - Markets Mojo
Another Wall Street analyst slashes Doximity stock price outlook - thestreet.com
Doximity shares plunge 20% on soft guidance and AI margin pressures - MSN
Doximity, Inc. 2026 Q4ResultsEarnings Call Presentation (NYSE:DOCS) 2026-05-16 - Seeking Alpha
Assessing Doximity (DOCS) Valuation After A Steep Share Price Decline - Yahoo Finance
Doximity (DOCS) Margin Compression Challenges Bullish AI Growth Narratives After FY 2026 Results - Sahm
Barclays Downgrades Doximity (NYSE:DOCS) to Hold - MarketBeat
Raymond James Upgrades Doximity (DOCS) - MSN
Why Is Doximity Stock Trending Right Now - Kalkine Media
RBC Capital Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $28 - Moomoo
Doximity Earnings Call: Cash‑Rich, Slower Growth, Big AI Bet - The Globe and Mail
Doximity Analyst Ratings and Price Targets | NYSE:DOCS - Benzinga
Doximity Inc (DOCS) Stock Price, Quote, News & History - Benzinga
Doximity (DOCS) founders report combined stakes equal to 77% voting power - Stock Titan
Doximity, Inc. Stock 12‑Month Price Target Cut to $24.92, Implies 38% Upside - TradingView
Leerink Partners Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
5.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):